Bank of New York Mellon Corp vs McKesson Corporation — how do they compare? Bank of New York Mellon Corp trades at $160.21 (market cap $108.78B), while McKesson Corporation trades at $894.99 (market cap $105.14B). The key difference: Bank of New York Mellon Corp and McKesson Corporation are close in size by market cap, and Bank of New York Mellon Corp pays the higher dividend (1.38%). Which is the better fit depends on your goals.
| BNY | MCK | |
|---|---|---|
Market Cap | $108.78B | $105.14B |
Sector | Financials | Health |
52-Week High | $162.35 | $995.69 |
52-Week Low | $101.00 | $659.01 |
Dividend Yield | 1.38% | 0.42% |
Enterprise Value | — | $111.67B |
Signals from Pluang's Aura AI — not financial advice
BNY stock trades at $159.44, up 1.14% on the day, near the analyst consensus price target of $170.36. The stock shows a bullish technical trend with strong moving average signals, and fundamentals are robust with consistent earnings beats, revenue growth to $19.76B in 2025, and a net income margin of 29.96%. Recent news highlights strategic moves in digital asset infrastructure and a dividend declaration.
The outlook for BNY is positive, supported by earnings momentum and digital innovation, but risks include high investing cash outflows and interest expenses. Analyst sentiment is mixed with a slight hold bias, yet institutional upgrades and a strong ROE of 15.34% offer upside potential amid market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
BNY Mellon is a global investment company involved in managing and servicing financial assets throughout the investment lifecycle. The bank provides financial services for institutions, corporations, and individual investors and delivers investment management and investment services in 35 countries and more than 100 markets. BNY Mellon is the largest global custody bank in the world, with about $41.1 trillion in under custody and administration (as of Dec. 31, 2020), and can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute, or restructure investments. BNY Mellon's asset-management division manages about $2.2 trillion in assets.
Read more on BNY →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →